bioRxiv Science⌕ Search

Biology subjects

Gosiewski, T.

Publications and source records attributed to Gosiewski, T..

2 recordsLinked to original sources

Spatial variability of the microbiome in chronic rhinosinusitis is associated with the patients' clinical characteristics but not with sinus ostia occlusion

BackgroundThe sinus microbiome in patients with chronic rhinosinusitis (CRS) is considered homogenous across the sinonasal cavity. The middle nasal meatus is the recommended sampling site for 16S rRNA sequencing. However, individuals with unusually high between-site variability between the middle meatus and the sinuses were identified in previous studies. This study aimed to identify which factors determine increased microbial heterogeneity between sampling sites in the sinuses. MethodologyIn this cross-sectional study samples for 16S rRNA sequencing were obtained from the middle meatus, the maxillary and the frontal sinus in 50 patients with CRS. The microbiome diversity between sampling sites was analysed in relation to the size of the sinus ostia and clinical metadata. ResultsIn approximately 15% of study participants, the differences between sampling sites within one patient were greater than between the patient and other individuals. Contrary to a popular hypothesis, obstruction of the sinus ostium resulted in decreased dissimilarity between the sinus and the middle meatus. The dissimilarity between the sampling sites was patient-specific: greater between-sinus differences were associated with greater meatus-sinus differences, regardless of the drainage pathway patency. Decreased spatial variability was observed in patients with nasal polyps and extensive mucosal changes in the sinuses. ConclusionsSampling from the middle meatus is not universally representative of the sinus microbiome. The differences between sites cannot be predicted from the patency of communication pathways between them.

microbiology↗

Pathogens in exacerbations of chronic rhinosinusitis differ in sensitivity to silver nanoparticles

PurposeThe significance of the microbiome in chronic rhinosinusitis (CRS) is not clear. Antimicrobials are recommended in acute exacerbations of the disease (AECRS). Increasing rates of antibiotic resistance stimulate research on alternative therapeutic options including silver nanoparticles (AgNPs), sometimes referred to as "colloidal silver". However, there are concerns regarding the safety of silver administration and the emergence of silver resistance. The aim of this cross-sectional observational study was to assess the sensitivity of sinonasal pathogens to AgNPs and compare it with the toxicity of AgNPs for nasal epithelial cells. MethodsNegatively charged AgNPs (12{+/-}5 nm) were synthetized using tannic acid. The minimal inhibitory concentration (MIC) for pathogens isolated from patients with AECRS was approximated. Cytotoxicity of AgNPs was tested in vitro on human nasal epithelial cells line. Results48 clinical isolates and 4 reference strains were included in the study (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Acinetobacter baumanii, Serratia marcescens, Enterobacter cloacae). The MIC values differed between isolates, even within the same species. All the isolates (including antibiotic resistant) were sensitive to AgNPs in concentrations nontoxic to human cells during 24 h exposition. However, 48 h exposition to AgNPs increased toxicity to human cells, narrowing their therapeutic window and enabling 19% of pathogens to resist the AgNPs biocidal action. ConclusionsAgNPs are effective against most pathogens isolated from patients with AECRS, but sensitivity testing may be necessary before application. Results of sensitivity testing for reference strains cannot be extrapolated to other strains of the same species.

microbiology↗